Search

everythinglearnresearchcommunity

for

Search:↓

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Two patients with stubborn hair loss grew hair after PDRN injections.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

LLPS is crucial for RALF signaling, aiding plant growth and stress resilience.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Higher RBP4 levels found in people with two types of hair loss.

PPARα agonists may help treat alopecia areata by reducing inflammation.

RXR and RAR proteins in skin may help with cell growth, hair growth, and gland function.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

RXRa is crucial for Th2 immune cell development and may link nutrition to immune health.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

The herbal mixture RAA promotes hair growth and could be an alternative treatment for hair loss.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Platelet rich plasma was slightly more effective than no treatment for hair loss in alopecia areata patients.

PDRN helps repair tissue and improve wound healing with a high safety profile.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Mutations in the RBPJ gene cause Adams-Oliver Syndrome.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Pine resin and abietic acid were found to promote hair growth in mice.